AEON Biopharma, Inc.
AEON Biopharma, Inc. (AEON) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AEON · as of Jun 8, 2026
Key Statistics
Explore AEON Biopharma, Inc. Data
aeon stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
aeon competitorsAEON
ABP
APM
BOLT
CING
CLNNStock Performance
Full HistoryAbout AEON Biopharma, Inc.
AEON Biopharma, Inc. a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, AB…
what is aeon biopharma, inc. · aeon stock overview · aeon biopharma, inc. company profile · who is aeon biopharma, inc. ceo · aeon AMEX · aeon biopharma, inc. headquarters · aeon biopharma, inc. business segments
About Stock Overview & Key Data
AEON Biopharma, Inc. (AEON) is a Healthcare company in the Biotechnology industry, listed on AMEX since Jul 24, 2023. As of the latest trading session, AEON stock price is $0.73, with a market capitalization of $8.7M. The stock has returned -15.60% over the past 12 months and -33.02% year-to-date.
According to 2 Wall Street analysts, the consensus rating for AEON Biopharma, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, AEON Biopharma, Inc. reported revenue of — and net income of -$39.2M. For detailed data — including AEON Biopharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AEON Biopharma, Inc. (AEON) stock price is $0.73. The stock is traded on AMEX under the ticker symbol AEON. The 52-week range is $0.63 – $1.45.